PL1915330T3 - Sposób fluorowania pochodnych anilidowych i fluorowane pochodne benzotiazolu jako środki obrazujące in vivo - Google Patents

Sposób fluorowania pochodnych anilidowych i fluorowane pochodne benzotiazolu jako środki obrazujące in vivo

Info

Publication number
PL1915330T3
PL1915330T3 PL06765263T PL06765263T PL1915330T3 PL 1915330 T3 PL1915330 T3 PL 1915330T3 PL 06765263 T PL06765263 T PL 06765263T PL 06765263 T PL06765263 T PL 06765263T PL 1915330 T3 PL1915330 T3 PL 1915330T3
Authority
PL
Poland
Prior art keywords
derivatives
fluorinate
benzothiazole
vivo imaging
imaging agents
Prior art date
Application number
PL06765263T
Other languages
English (en)
Polish (pl)
Inventor
Anthony Eamon Storey
Clare Louise Jones
Denis Raymond Christophe Bouvet
Nicolas Lasbistes
Steven Michael Fairway
Lorenzo Williams
Alexander Mark Gibson
Robert James Nairne
Farhad Karimi
Bengt Langstrom
Original Assignee
Ge Healthcare Ltd
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd, Ge Healthcare As filed Critical Ge Healthcare Ltd
Publication of PL1915330T3 publication Critical patent/PL1915330T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C07C209/74Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by halogenation, hydrohalogenation, dehalogenation, or dehydrohalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24Stationary reactors without moving elements inside
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • C07C211/46Aniline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/24Stationary reactors without moving elements inside
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL06765263T 2005-08-12 2006-08-11 Sposób fluorowania pochodnych anilidowych i fluorowane pochodne benzotiazolu jako środki obrazujące in vivo PL1915330T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0516564.2A GB0516564D0 (en) 2005-08-12 2005-08-12 Fluorination process
EP06765263.6A EP1915330B1 (en) 2005-08-12 2006-08-11 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
PCT/GB2006/003009 WO2007020400A1 (en) 2005-08-12 2006-08-11 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents

Publications (1)

Publication Number Publication Date
PL1915330T3 true PL1915330T3 (pl) 2015-03-31

Family

ID=35098197

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06765263T PL1915330T3 (pl) 2005-08-12 2006-08-11 Sposób fluorowania pochodnych anilidowych i fluorowane pochodne benzotiazolu jako środki obrazujące in vivo

Country Status (20)

Country Link
US (3) US8410312B2 (deDer)
EP (1) EP1915330B1 (deDer)
JP (2) JP5566605B2 (deDer)
KR (2) KR101409608B1 (deDer)
CN (2) CN101282920B (deDer)
AU (1) AU2006281216B2 (deDer)
BR (1) BRPI0614752B1 (deDer)
CA (1) CA2618448C (deDer)
DK (1) DK1915330T3 (deDer)
ES (1) ES2527864T3 (deDer)
GB (1) GB0516564D0 (deDer)
IL (1) IL188933A0 (deDer)
MX (2) MX341173B (deDer)
NO (1) NO341560B1 (deDer)
NZ (1) NZ565333A (deDer)
PL (1) PL1915330T3 (deDer)
PT (1) PT1915330E (deDer)
RU (1) RU2419601C2 (deDer)
WO (1) WO2007020400A1 (deDer)
ZA (1) ZA200801860B (deDer)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
US20100150835A1 (en) * 2007-02-27 2010-06-17 Bengt Langstrom Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate
WO2009027452A2 (en) * 2007-08-30 2009-03-05 Ge Healthcare Limited Radiopharmaceutical composition
US8980221B2 (en) 2008-01-03 2015-03-17 Ge Healthcare Limited Fluoride processing method
PT2338059E (pt) 2008-09-23 2015-08-03 Wista Lab Ltd Ligandos para moléculas de tau agregada
GB0921967D0 (en) * 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel Aryloxyanilide Derivatives
GB201019303D0 (en) 2010-11-15 2010-12-29 Strom Hans E P Agents and methods for visualising analytes
CN103613589B (zh) * 2013-11-29 2016-03-30 江苏华益科技有限公司 一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
WO2016087653A1 (en) 2014-12-04 2016-06-09 Ge Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
JP6485914B2 (ja) * 2015-10-28 2019-03-20 日本メジフィジックス株式会社 フルテメタモルの製造方法
JP6955347B2 (ja) * 2017-02-28 2021-10-27 日本メジフィジックス株式会社 フルテメタモルの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878206A (en) * 1973-06-06 1975-04-15 Morton Norwich Products Inc 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines
FR2449677B1 (fr) 1979-02-26 1986-03-28 Fabre Sa Pierre Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
FR2693781B1 (fr) * 1992-07-15 1994-10-28 Otis Elevator Co Dispositif de réglage de la tension d'un câble faisant boucle.
DE4402056A1 (de) 1994-01-25 1995-07-27 Basf Ag p-Phenylendiamin-Derivate und sie enthaltende fungizide Mittel
US7270800B2 (en) * 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
GB0115927D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles
RU2440995C2 (ru) * 2003-03-14 2012-01-27 Юнивесити Оф Питсбэг Производные бензотиазола, фармацевтическая композиция, обладающая свойством связывать амилоид, и способ детекции отложений амилоида у млекопитающего
CA2438032C (en) 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
AU2005270026A1 (en) * 2004-07-02 2006-02-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process

Also Published As

Publication number Publication date
CA2618448A1 (en) 2007-02-22
ES2527864T3 (es) 2015-01-30
HK1177463A1 (zh) 2013-08-23
AU2006281216B2 (en) 2012-01-19
US8410312B2 (en) 2013-04-02
IL188933A0 (en) 2008-04-13
US20150328344A1 (en) 2015-11-19
CN101282920B (zh) 2014-06-04
MX2008002068A (es) 2008-04-16
AU2006281216A1 (en) 2007-02-22
PT1915330E (pt) 2015-01-16
ZA200801860B (en) 2008-12-31
KR101392538B1 (ko) 2014-05-07
RU2419601C2 (ru) 2011-05-27
US9468694B2 (en) 2016-10-18
CN102731432A (zh) 2012-10-17
KR20130114279A (ko) 2013-10-16
GB0516564D0 (en) 2005-09-21
KR101409608B1 (ko) 2014-06-18
NO341560B1 (no) 2017-12-04
EP1915330B1 (en) 2014-12-10
NZ565333A (en) 2011-07-29
EP1915330A1 (en) 2008-04-30
US20130225829A1 (en) 2013-08-29
WO2007020400A1 (en) 2007-02-22
BRPI0614752B1 (pt) 2024-01-09
JP2009507775A (ja) 2009-02-26
DK1915330T3 (en) 2015-01-19
NO20081167L (no) 2008-03-05
RU2008103989A (ru) 2009-09-20
MX341173B (es) 2016-08-10
US20100234611A1 (en) 2010-09-16
BRPI0614752A2 (pt) 2012-12-04
CA2618448C (en) 2014-05-06
JP2014028837A (ja) 2014-02-13
KR20080035618A (ko) 2008-04-23
CN102731432B (zh) 2015-10-21
US9126961B2 (en) 2015-09-08
CN101282920A (zh) 2008-10-08
JP5566605B2 (ja) 2014-08-06

Similar Documents

Publication Publication Date Title
ZA200801860B (en) Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
FR24C1006I1 (fr) Composes comprenant des chaines aminoalcool courtes et des complexes metalliques en imagerie medicale
IL174674A0 (en) In vivo imaging device and method of manufacture thereof
PL2012833T3 (pl) Znakowane radiologicznie pochodne dihydrotrabenazyny i ich zastosowanie jako środki do obrazowania
PL2276485T3 (pl) Stosowanie epotilonu D w leczeniu chorób związanych z Tau, w tym choroby Alzheimera
GB2423933B (en) Medical apparatus and method of use thereof
ZA200709751B (en) Thiazole compounds and methods of use
IL188031A0 (en) Use of thiazole derivatives and analogues in the treatment of cancer
EP2049019A4 (en) ITERATIVE METHOD FOR DOSE REDUCTION AND IMAGE ENLARGEMENT IN TOMOGRAPHY
IL228535A (en) Method for diagnosing Alzheimer's disease in a patient and its kit
ZA200707531B (en) N-(N-Sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
EP2011513A4 (en) THERAPEUTIC AGENTS AGAINST ALZHEIMER DISEASE AND CANCER
EP2217146A4 (en) NANOMETRIC SCALE CONTRAST AGENTS AND METHODS OF USE
IL200549A0 (en) 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
ZA200710800B (en) Melthod and apparatus for the non-invasive sensing of glucose in a human subject
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
GB0515758D0 (en) Improvements in and relating to optical coherence tomography
IL188032A0 (en) Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
EP1951709A4 (en) IMIDAZOLIDINONE COMPOUNDS AS A BETA SECRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
GB0404209D0 (en) Materials and methods for treatment of allergic disease
EP1859725A4 (en) ENDOSCOPE AND REPAIR METHOD
ZA200711163B (en) Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue
HK1119661A (en) Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE